BAY 43-9006
Term · Oncology and biomedicine · MLC-T-ONC-000934
A drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. BAY 43-9006 blocks certain proteins, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. BAY 43-9006 is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called Nexavar and sorafenib tosylate.
| Identifier | MLC-T-ONC-000934 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Nexavar; sorafenib tosylate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000934",
"term": "BAY 43-9006",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. BAY 43-9006 blocks certain proteins, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. BAY 43-9006 is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called Nexavar and sorafenib tosylate.",
"synonyms": [
"Nexavar",
"sorafenib tosylate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/bay-43-9006/"
}
Record 3,315 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.